Related references
Note: Only part of the references are listed.New strategies to treat AML: novel insights into AML survival pathways and combination therapies
Ramya Nair et al.
LEUKEMIA (2021)
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
Heikki Kuusanmaki et al.
HAEMATOLOGICA (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development
Hitoshi Kiyoi et al.
CANCER SCIENCE (2020)
Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor-B cell acute lymphoblastic leukemia
Shannon R. Sweeney et al.
MOLECULAR CARCINOGENESIS (2020)
Charting the Fragmented Landscape of Drug Synergy
Christian T. Meyer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Computational data mining method for isotopomer analysis in the quantitative assessment of metabolic reprogramming
Fumio Matsuda et al.
SCIENTIFIC REPORTS (2020)
Metabolomics in acute myeloid leukemia
Anna V. Wojcicki et al.
MOLECULAR GENETICS AND METABOLISM (2020)
The Combined Treatment with the FLT3-Inhibitor AC220 and the Complex I Inhibitor Iacs-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells
Xiyuan Lu et al.
BLOOD (2020)
Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia
Eunice S. Wang
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2019)
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Rory M. Shallis et al.
BLOOD REVIEWS (2019)
Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
Nicolas Chapuis et al.
FRONTIERS IN ONCOLOGY (2019)
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
Lucille Stuani et al.
BMC BIOLOGY (2019)
Metabolic Plasticity of Acute Myeloid Leukemia
Johanna Kreitz et al.
CELLS (2019)
Three-Dimensional Leukemia Co-Culture System for In Vitro High-Content Metabolomics Screening
Xiyuan Lu et al.
SLAS DISCOVERY (2019)
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis
Xin You et al.
CANCER COMMUNICATIONS (2019)
Advancing Drug Discovery via Artificial Intelligence
H. C. Stephen Chan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
Isabel Castro et al.
CELLS (2019)
Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy
Ida Sofie Gronningsaeter et al.
CELLS (2019)
HMDB 4.0: the human metabolome database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition
Paolo Gallipoli et al.
BLOOD (2018)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
Missing Value Imputation Approach for Mass Spectrometry-based Metabolomics Data
Runmin Wei et al.
SCIENTIFIC REPORTS (2018)
FLT3 inhibitors in acute myeloid leukemia
Mei Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Mitochondrial Complex I Inhibitor Iacs-010759 Reverses the NOTCH1-Driven Metabolic Reprogramming in T-ALL Via Blockade of Oxidative Phosphorylation: Synergy with Chemotherapy and Glutaminase Inhibition
Natalia Baran et al.
BLOOD (2018)
A Metabolomics Approach to Pharmacotherapy Personalization
Elena E. Balashova et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
A complete workflow for high-resolution spectral-stitching nanoelectrospray direct-infusion mass-spectrometry-based metabolomics and lipidomics
Andrew D. Southam et al.
NATURE PROTOCOLS (2017)
The hypoxia signalling pathway in haematological malignancies
Marta Irigoyen et al.
ONCOTARGET (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML
Sanduni U. Liyanage et al.
BLOOD (2017)
An update of current treatments for adult acute myeloid leukemia
Herve Dombret et al.
BLOOD (2016)
NAD+ metabolism: Bioenergetics, signaling and manipulation for therapy
Yue Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2016)
Oxidative stress and hypoxia in normal and leukemic stem cells
Ugo Testa et al.
EXPERIMENTAL HEMATOLOGY (2016)
Cell intrinsic and extrinsic regulation of leukemia cell metabolism
Yajian Jiang et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Application of metabolomics to investigate the antitumor mechanism of flavopiridol in MCF-7 breast cancer cells
Xiaojian Shao et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia
Mark A. Gregory et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
How to really perform high throughput metabolomic analyses efficiently?
Baninia Habchi et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2016)
Hypoxia and Hypoxia-inducible Factors in Leukemias
Margaux Deynoux et al.
FRONTIERS IN ONCOLOGY (2016)
Bioluminescence Assay for Cell Viability
G. Yu. Lomakina et al.
BIOCHEMISTRY-MOSCOW (2015)
Systematic synergy modeling: understanding drug synergy from a systems biology perspective
Di Chen et al.
BMC SYSTEMS BIOLOGY (2015)
Hypoxia regulates proliferation of acute myeloid leukemia and sensitivity against chemotherapy
Heidrun Drolle et al.
LEUKEMIA RESEARCH (2015)
Inhibition of c-Kit by tyrosine kinase inhibitors
Allison Galanis et al.
HAEMATOLOGICA (2015)
Phase I Study of Quizartinib Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication Status
Jorge E. Cortes et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The emerging role of D-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms
Dinesh Rakheja et al.
FRONTIERS IN ONCOLOGY (2013)
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
Stefan Gross et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Patrick P. Zarrinkar et al.
BLOOD (2009)
Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines
Stefano Tiziani et al.
PLOS ONE (2009)
ProteoWizard: open source software for rapid proteomics tools development
Darren Kessner et al.
BIOINFORMATICS (2008)
Bioluminescent assays for high-throughput screening
Frank Fan et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2007)
Markov chain Monte Carlo algorithm based metabolic flux distribution analysis on Corynebacterium glutamicum
Visakan Kadirkamanathan et al.
BIOINFORMATICS (2006)
Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures.: Application in 1H NMR metabonomics
Frank Dieterle et al.
ANALYTICAL CHEMISTRY (2006)
Share Paper
